EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics

Haewon Byeon

Indian Journal of Pathology and Microbiology · 2026-07 · 69 (3) · 586-587

DOI: 10.4103/ijpm.ijpm_488_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, online erschienen am 28.09.2026. Verfasst von Haewon Byeon. Beteiligte Einrichtung: Worker's Care and Digital Health Lab, Korea University of Technology and Education (KOREA TECH), Cheonan, South Korea. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Worker's Care and Digital Health Lab, Korea University of Technology and Education (KOREA TECH), Cheonan, South Korea.

Zitieren

APA

Byeon, H. (2026). Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics. Indian Journal of Pathology and Microbiology, 69(3), 586-587. https://doi.org/10.4103/ijpm.ijpm_488_25

Vancouver

Byeon H. Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics. Indian Journal of Pathology and Microbiology. 2026;69(3):586-587. doi:10.4103/ijpm.ijpm_488_25

BibTeX
@article{Byeon2026,
  author = {Byeon, Haewon},
  title = {Is Rspo1 a friend or foe in ESCC? Rethinking wnt signaling in tumor prognostics},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2026},
  volume = {69},
  number = {3},
  pages = {586--587},
  doi = {10.4103/ijpm.ijpm_488_25}
}
Kostenlos starten →